Clinical appraisal of shock following acute myocardial infarction.
D000136:Acid-Base Equilibrium; D000368:Aged; D001002:Anuria / Q000150:complications; D001794:Blood Pressure; D001831:Body Temperature; D002496:Central Venous Pressure; D003221:Confusion / Q000150:complications; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use*; D007545:Isoproterenol / Q000627:therapeutic use*; D008297:Male; D008680:Metaraminol / Q000627:therapeutic use*; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications; D009638:Norepinephrine / Q000627:therapeutic use*; D010042:Ouabain / Q000627:therapeutic use*; D010643:Phenoxybenzamine / Q000627:therapeutic use*; D012770:Shock, Cardiogenic / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology / Q000401:mortality; D013997:Time Factors; D014474:Unconsciousness
D010643:Phenoxybenzamine; D010042:Ouabain; D008680:Metaraminol; D007545:Isoproterenol; D006854:Hydrocortisone; D009638:Norepinephrine